Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Shannon

Showing results (61-70 of 245) with videos related to

Pageof 25
Sort By:
The Journal of Biological Chemistry|December 16, 2000
Cold shock domain factors activate the granulocyte-macrophage colony-stimulating factor promoter in stimulated Jurkat T cellsP Diamond, M F Shannon, M A Vadas, et al.
Immunity|November 1, 1996
High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promotersS R Himes, L S Coles, R Reeves, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1994
Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6C Kunsch, R K Lang, C A Rosen, et al.
Immunology and Cell Biology|April 1, 1987
Human myeloid growth factorsM A Vadas, A F Lopez, M F Shannon, et al.
The Journal of Clinical Investigation|June 15, 1997
Deoxyribonucleic acid triplex formation inhibits granulocyte macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cellsM Kochetkova, P O Iversen, A F Lopez, et al.
The Journal of Biological Chemistry|July 11, 2000
Functional interaction between the HIV transactivator Tat and the transcriptional coactivator PC4 in T cellsA F Holloway, F Occhiodoro, G Mittler, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 1, 1997
Frequency and duration of remission after isolated limb perfusion for melanomaJ F Thompson, J A Hunt, K F Shannon, et al.
Critical Reviews in Immunology|January 1, 1997
Signals for activation of the GM-CSF promoter and enhancer in T cellsM F Shannon, L S Coles, M A Vadas, et al.
The Australasian Journal of Dermatology|November 18, 2009
Topical diphencyprone immunotherapy for cutaneous metastatic melanomaDiona L Damian, Kerwin F Shannon, Robyn P Saw, et al.
International Immunology|December 11, 1999
Nuclear factor of activated T cells contributes to the function of the CD28 response region of the granulocyte macrophage-colony stimulating factor promoterC Shang, J Attema, D Cakouros, et al.
Pageof 25

Showing results (61-70 of 245) with videos related to

Sort By:
Pageof 25
The Journal of Biological Chemistry|December 16, 2000
Cold shock domain factors activate the granulocyte-macrophage colony-stimulating factor promoter in stimulated Jurkat T cellsP Diamond, M F Shannon, M A Vadas, et al.
Immunity|November 1, 1996
High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promotersS R Himes, L S Coles, R Reeves, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1994
Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NF-IL-6C Kunsch, R K Lang, C A Rosen, et al.
Immunology and Cell Biology|April 1, 1987
Human myeloid growth factorsM A Vadas, A F Lopez, M F Shannon, et al.
The Journal of Clinical Investigation|June 15, 1997
Deoxyribonucleic acid triplex formation inhibits granulocyte macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cellsM Kochetkova, P O Iversen, A F Lopez, et al.
The Journal of Biological Chemistry|July 11, 2000
Functional interaction between the HIV transactivator Tat and the transcriptional coactivator PC4 in T cellsA F Holloway, F Occhiodoro, G Mittler, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 1, 1997
Frequency and duration of remission after isolated limb perfusion for melanomaJ F Thompson, J A Hunt, K F Shannon, et al.
Critical Reviews in Immunology|January 1, 1997
Signals for activation of the GM-CSF promoter and enhancer in T cellsM F Shannon, L S Coles, M A Vadas, et al.
The Australasian Journal of Dermatology|November 18, 2009
Topical diphencyprone immunotherapy for cutaneous metastatic melanomaDiona L Damian, Kerwin F Shannon, Robyn P Saw, et al.
International Immunology|December 11, 1999
Nuclear factor of activated T cells contributes to the function of the CD28 response region of the granulocyte macrophage-colony stimulating factor promoterC Shang, J Attema, D Cakouros, et al.
Pageof 25